Rob Brougham
Direktor/Vorstandsmitglied bei Cognetivity Ltd.
Ursprung des Netzwerks ersten Grades von Rob Brougham
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cognetivity Ltd.
 Cognetivity Ltd. BiotechnologyHealth Technology Cognetivity Ltd. engages in the research and experimental development on biotechnology. It focuses on the diagnosis and prognosis of dementia. Its advisory board includes leaders in artificial intelligence, medical diagnostics, old age psychiatry and neurology, cognitive analysis, and brain mapping. The company was founded by Sina Habibi and Seyed Mahdi Khaligh Razavi and is headquartered in London, the United Kingdom.
3
| Subsidiary | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rob Brougham
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| COGNETIVITY NEUROSCIENCES LTD. | Biotechnology | Founder Compliance Officer Founder | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Cambridge University Entrepreneurs
 Cambridge University Entrepreneurs Miscellaneous Commercial ServicesCommercial Services Cambridge University Entrepreneurs operates as a student society. It organizes business and entrepreneurial events and training opportunities for students throughout the year and runs student-run business creation competitions in the world. The company was founded in 1999 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fluorogenics Ltd.
 Fluorogenics Ltd. Miscellaneous Commercial ServicesCommercial Services Part of New England Biolabs, Inc., Fluorogenics Ltd. is a British company that specializes in sample-to-result integrated analyzers and real-time PCR lyophilized reagents. The company is based in Salisbury, UK. The company brings extensive technical expertise to the market and offers leading performance ambient stable solutions through their ISO 13485:2016 certified facilities and ADMIX custom product service. The company was founded in 2011 by Martin Alan Lee, who has been the CEO since then. Fluorogenics was acquired by New England Biolabs, Inc. on May 10, 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Loughborough University | College/University | Undergraduate Degree | |
| Centillion Technology Ltd. | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 7 |
| Kanada | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 5 |
| Founder | 4 |
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 3 |
| Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Rob Brougham
- Unternehmensverbindungen
